DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20151604

Hysteroscopy and pain: what risk factors should we consider in office hysteroscopy? are there really any?

Antonio A. Paulo, Jose Damasceno-Costa, Antonio Pipa, Vera M. Afreixo

Abstract


Background: Office hysteroscopy is the gold standard in abnormal uterine bleeding and an indispensable tool in modern gynecology. It is becoming increasingly popular leading to examinations and even operations without anesthesia as it is accurate, cheap and well tolerated. However, pain is still a limitation. The objective of the study was to determine if pain perception is linked to clinical predictors and how well they correlate with pain score.

Methods: Prospective observational trial enrolled one hundred and four women; four cases were excluded. One hundred cases were included and analyzed. Selection criteria: patients scheduled for Office Hysteroscopy who accepted to participate and had no contraindication for procedure.

Results: A ten centimeter visual analogue scale was used for pain evaluation. Presumed variables such as menopause, pelvic pain, previous cesarean section and cervical surgery, and body mass index were analyzed by ordered regression using standard statistical software tools.

Conclusions: Correlation between predictive factors and pain reporting showed no significance (p>0.05) except for body mass index which was found to significantly correlate to discomfort (p<0.05).


Keywords


Office hysteroscopy, Pain, Predictive factors

Full Text:

PDF

References


Campo R, Van BY, Rombauts L, Brosens I, Gordts S. Office mini-hysteroscopy. Hum Reprod Update. 1999;5(1):73-81.

Fatemi HM, Kasius JC, Timmermans A, van DJ, Fauser BC, Devroey P. Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization. Hum Reprod. 2010;25(8):1959-65.

Ergenoglu M, Yeniel AO, Yildirim N, Akdemir A, Yucebilgin S. Recurrent uterine rupture after hysterescopic resection of the uterine septum. Int J Surg Case Rep. 2013;4(2):182-4.

Buchanan EM, Weinstein LC, Hillson C. Endometrial cancer. Am Fam Physician. 2009;80(10):1075-80.

Clark TJ, Barton PM, Coomarasamy A, Gupta JK, Khan KS. Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies. BJOG. 2006;113(5):502-10.

Van DH, De KCD, Van DTSA, Louwe LA, Trimbos-Kemper GC, Jansen FW. A randomised comparison of vaginoscopic office hysteroscopy and saline infusion sonography: a patient compliance study. BJOG. 2008;115(10):1232-7.

Guin G, Sandhu SK, Lele A, Khare S. Hysteroscopy in evaluation of abnormal uterine bleeding. J Obstet Gynaecol India. 2011;61(5):546-9.

Guruwadayarhalli B, Jones SE, Srinivasan V. Hysteroscopy in the diagnosis of postmenopausal bleeding. Menopause Int. 2007;13(3):132-4.

Lee DO, Jung MH, Kim HY. Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding. J Obstet Gynaecol Res. 2011;37(10):1423-6.

Pal L, Lapensee L, Toth TL, Isaacson KB. Comparison of office hysteroscopy, transvaginal ultrasonography and endometrial biopsy in evaluation of abnormal uterine bleeding. JSLS. 1997;1(2):125-30.

Paulo AA, Solheiro MH, Paulo CO. Is pain better tolerated with mini-hysteroscopy than with conventional device? A systematic review and meta-analysis: Hysteroscopy scope size and pain. Arch Gynecol Obstet. 2015.

Garbin O, Kutnahorsky R, Gollner JL, Vayssiere C. Vaginoscopic versus conventional approaches to outpatient diagnostic hysteroscopy: a two-centre randomized prospective study. Hum Reprod. 2006;21(11):2996-3000.

Siristatidis C, Chrelias C, Salamalekis G, Kassanos D. Office hysteroscopy: current trends and potential applications: a critical review. Arch Gynecol Obstet. 2010;282(4):383-8.

Cooper NA, Smith P, Khan KS, Clark TJ. Vaginoscopic approach to outpatient hysteroscopy: a systematic review of the effect on pain. BJOG. 2010;117(5):532-9.

Angelis DC, Santoro G, Re ME, Nofroni I. Office hysteroscopy and compliance: mini-hysteroscopy versus traditional hysteroscopy in a randomized trial. Hum Reprod. 2003;18(11):2441-5.

Paulo AA, Solheiro MH, Paulo CO, Afreixo VM. What proportion of women refers moderate to severe pain during office hysteroscopy with a mini-hysteroscope? A systematic review and meta-analysis. Arch Gynecol Obstet. 2015.

Cicinelli E, Rossi AC, Marinaccio M, Matteo M, Saliani N, Tinelli R. Predictive factors for pain experienced at office fluid minihysteroscopy. J Minim Invasive Gynecol. 2007;14(4):485-8.

Fonseca MD, Sessa FV, Resende JA, Jr., Guerra CG, Andrade CM, Jr., Crispi CP. Identifying Predictors of Unacceptable Pain at Office Hysteroscopy. J Minim Invasive Gynecol. 2014.

Ventura Sessa F. Cesarean-Section as Predictor of Pain in Office Hysteroscopy: An Observational Sectional Study with 558 Patients. Journal of Minimally Invasive Gynecology. 2012;19(6).

Raymundo TS, Fonseca MF, Santos LC, Crispi CP, Andrade CM, Lamblet MF. Predictors of Pain during and after Office Hysteroscopy. J Minim Invasive Gynecol. 2008;15(6):81S-2S.

Fonseca MF CC, Andrade CM Jr, Santos LCS, Rodrigues RF. M. L. Uterine Retroversion as Predictor of Pain during and Fifteen Minutes after Office Hysteroscopy without Anesthesia. Journal of Minimally Invasive Gynecology. 2009;16(6).

Mazzon I, Favilli A, Grasso M, Horvath S, Bini V, Di Renzo GC. Pain in diagnostic hysteroscopy: a multivariate analysis after a randomized, controlled trial. Fertil Steril. 2014;102(5):1398-403.

Kokanali MK, Cavkaytar S, Guzel AI, Topcu HO, Eroglu E, Aksakal O. Impact of preprocedural anxiety levels on pain perception in patients undergoing office hysteroscopy. J Chin Med Assoc. 2014;77(9):477-81.

Carta G, Palermo P, Marinangeli F, Piroli A, Necozione S, De Lellis V. Waiting time and pain during office hysteroscopy. J Minim Invasive Gynecol. 2012;19(3):360-4.

Angioli R, De CNC, Plotti F, Cafa EV, Dugo N, Damiani P. Use of music to reduce anxiety during office hysteroscopy: prospective randomized trial. J Minim Invasive Gynecol. 2014;21(3):454-9.

Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 2004;150(2):161-71.

Ziomkiewicz A, Ellison PT, Lipson SF, Thune I, Jasienska G. Body fat, energy balance and estradiol levels: a study based on hormonal profiles from complete menstrual cycles. Hum Reprod. 2008;23(11):2555-63.

Pfeiler G, Konigsberg R, Hadji P, Fitzal F, Maroske M, Dressel-Ban G. Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer. Br J Cancer. 2013;109(6):1522-7.

Corbould AM, Bawden MJ, Lavranos TC, Rodgers RJ, Judd SJ. The effect of obesity on the ratio of type 3 17beta-hydroxysteroid dehydrogenase mRNA to cytochrome P450 aromatase mRNA in subcutaneous abdominal and intra-abdominal adipose tissue of women. Int J Obes Relat Metab Disord. 2002;26(2):165-75.